Skip to content

CLDXCELLDEX THERAPEUTICS INC

CUSIP 15117B202 · common stock

3 tracked investors held CELLDEX THERAPEUTICS INC (CLDX) at the end of Q3 2026, worth $149.4M in total. The largest holder was Julian Baker, with 0.4% of its portfolio.

Holders · Q3 2026
3
New holders
0
Value held
$149.4M
Quarter-end price (est.)
$32.41

Investors holding CLDX · Q3 2026

InvestorWeightSharesValueChange
Julian Baker
Baker Bros. Advisors LP
0.40%2,564,984$83.1MADD+116.9%
Ken Fisher
Fisher Asset Management, LLC
0.01%1,246,855$40.4MADD+26.5%
Adar1 Capital Management
ADAR1 Capital Management, LLC
1.10%799,304$25.9MADD+29.0%

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026300$149.4M$32.41
Q2 2026300$103.7M$37.21
Q1 2026300$66.8M$31.72
Q4 2025300$61.1M$27.16